Scholarly Index
Florence Dalenc
Inserm; 15,437 total citations; 452 total publications; best world rank #85
Inserm
15,437Total citations
452Total publications
55H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Advanced Breast Cancer Therapies | Lifetime | 203 | FR 12 | 98.30 |
| Cancer Treatment and Pharmacology | Lifetime | 699 | FR 51 | 98.15 |
| HER2/EGFR in Cancer Research | Lifetime | 575 | FR 29 | 97.67 |
| Breast Cancer Treatment Studies | Lifetime | 841 | FR 41 | 97.66 |
| Chemotherapy-related skin toxicity | Lifetime | 954 | FR 42 | 79.11 |
| Cancer Treatment and Pharmacology | 2021-2025 | 85 | FR 7 | 98.39 |
| HER2/EGFR in Cancer Research | 2021-2025 | 90 | FR 8 | 98.57 |
| Advanced Breast Cancer Therapies | 2021-2025 | 95 | FR 10 | 98.36 |
| Breast Cancer Treatment Studies | 2021-2025 | 207 | FR 12 | 97.60 |
| PARP inhibition in cancer therapy | 2021-2025 | 353 | FR 23 | 89.82 |
| Cancer Diagnosis and Treatment | 2021-2025 | 411 | FR 18 | 83.24 |
| Cancer-related Molecular Pathways | 2021-2025 | 487 | FR 12 | 81.21 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 274 | FR 6 | 78.90 |